Repeated episodes of neutropenia triggered by mirtazapine

Psychosomatics

Volumn 50, Issue 3, 2009, Pages 299-300

  Civalier, Kari A ^a   Krahn, Lois E ^a   Agrwal, Neera ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; MIRTAZAPINE; MORPHINE; NARCOTIC AGENT; ONDANSETRON;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; FEMALE; HUMAN; INSOMNIA; LABORATORY TEST; LETTER; NAUSEA; NEUTROPENIA;

EID: 67650872548     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.50.3.299     Document Type: Letter

References (7)

1. Hartmann PM: Mirtazapine: a newer antidepressant. Am Fam Physician 1999; 59:159-161
2. Ahmed A: Neutropenia associated with mirtazapine use: is a drop in the neutrophil count in symptomatic older adults a cause for concern? J Am Geriatr Soc 2002; 50: 1461-1463
3. Anghelescu I, Klawe C, Dahmen N: Venlafaxine in a patient with idiopathic leukopenia and mirtazapine-induced severe neutropenia (letter). J Clin Psychiatry 2002; 63:838
4. Davis J, Barkin RL: Clinical pharmacology of mirtazapine: revisited (comment). Am Fam Physician 1999; 60:1101 (Pubitemid 29459397)
5. Kasper S, Praschak-Rieder N, Tauscher J, et al: A risk- benefit assessment of mirtazapine in the treatment of depression. Drug Saf 1997; 17:251-264 (Pubitemid 27466515)
6. Montgomery SA: Safety of mirtazapine: a review. Int Clin Psychopharmacol 1995; 10:(suppl 4):37-45
7. Ozcanli T, Unsalver B, Ozdemir S, et al: Sertraline- and mirtazapine-induced severe neutropenia (letter). Am J Psychiatry 2005; 162:1386 (Pubitemid 40905597)